Merida Biosciences

1 trends tracked about this subject — the full history, oldest to newest below.

↓ Cooling Business

Eli Lilly is expanding its autoimmune portfolio through the acquisition of Merida Biosciences in a deal valued at up to $2.875 billion.

8 sources 8 articles v 8 45m ago